ZACKS INVESTMENT MANAGEMENT
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1086483
Chicago, IL
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$24,596,316
-$1,075,647 QoQ
Shares Held
55,082
-2.7% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ZACKS INVESTMENT MANAGEMENT holds $41,029,792 across 10 Biotechnology names. VRTX ranks #1 (59.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
55,082 | $24,596,316 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
17,919 | $4,628,835 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
36,889 | $3,407,804 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,857 | $2,599,644 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
30,852 | $1,993,963 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
118,702 | $1,069,505 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
14,879 | $1,043,761 | |
| 8 | ARVN |
Arvinas, Inc.
|
66,978 | $709,966 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,596,316 | 55,082 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,671,963 | 56,626 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,725,301 | 58,026 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,181,483 | 54,316 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $41,718,761 | 86,050 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,203,363 | 52,653 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,060,058 | 62,484 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,013,050 | 59,765 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,711,737 | 54,333 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $273,023 | 671 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $430,737 | 1,224 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $521,125 | 1,654 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,240,734 | 14,685 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,949,904 | 13,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,253,910 | 29,291 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,545,947 | 28,915 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $227,281 | 1,253 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,343,279 | 31,460 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,520,388 | 39,650 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,794,065 | 28,747 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,113,067 | 37,164 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $13,027,661 | 44,875 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $10,074,089 | 42,337 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||